Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
April 3, 2007
Additional interaction of allophenylnorstatine-containing tripeptidomimetics with malarial aspartic protease plasmepsin II
Koushi Hidaka, Tooru Kimura, Yumi Tsuchiya, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 17, 2010
Improvement of both plasmepsin inhibitory activity and antimalarial activity by 2-aminoethylamino substitution
Takuya Miura, Koushi Hidaka, Tsuyoshi Uemura, et al.
Bioorganic & Medicinal Chemistry
|
October 28, 2008
Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin
Koushi Hidaka, Tooru Kimura, Adam J Ruben, et al.
The American Journal of Tropical Medicine and Hygiene
|
December 21, 2017
Impact of Sickle Cell Trait and Naturally Acquired Immunity on Uncomplicated Malaria after Controlled Human Malaria Infection in Adults in Gabon
Bertrand Lell, Benjamin Mordmüller, Jean-Claude Dejon Agobe, et al.
Nature
|
February 16, 2017
Sterile protection against human malaria by chemoattenuated PfSPZ vaccine
Benjamin Mordmüller, Güzin Surat, Heimo Lagler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 30, 2019
Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian Adults
Said A Jongo, L W Preston Church, Ali T Mtoro, et al.
The American Journal of Tropical Medicine and Hygiene
|
November 17, 2017
Advancing Global Health through Development and Clinical Trials Partnerships: A Randomized, Placebo-Controlled, Double-Blind Assessment of Safety, Tolerability, and Immunogenicity of PfSPZ Vaccine for Malaria in Healthy Equatoguinean Men
Ally Olotu, Vicente Urbano, Ali Hamad, et al.
The American Journal of Tropical Medicine and Hygiene
|
June 27, 2018
Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of <i>Plasmodium falciparum</i> Sporozoite Vaccine in Tanzanian Adults
Said A Jongo, Seif A Shekalaghe, L W Preston Church, et al.
The American Journal of Tropical Medicine and Hygiene
|
April 18, 2019
Safety and Differential Antibody and T-Cell Responses to the <i>Plasmodium falciparum</i> Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants
Said A Jongo, L W Preston Church, Ali T Mtoro, et al.
The Lancet. Infectious Diseases
|
February 21, 2017
Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial
Mahamadou S Sissoko, Sara A Healy, Abdoulaye Katile, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Bioorganic & Medicinal Chemistry Letters
|
April 3, 2007
Additional interaction of allophenylnorstatine-containing tripeptidomimetics with malarial aspartic protease plasmepsin II
Koushi Hidaka, Tooru Kimura, Yumi Tsuchiya, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 17, 2010
Improvement of both plasmepsin inhibitory activity and antimalarial activity by 2-aminoethylamino substitution
Takuya Miura, Koushi Hidaka, Tsuyoshi Uemura, et al.
Bioorganic & Medicinal Chemistry
|
October 28, 2008
Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin
Koushi Hidaka, Tooru Kimura, Adam J Ruben, et al.
The American Journal of Tropical Medicine and Hygiene
|
December 21, 2017
Impact of Sickle Cell Trait and Naturally Acquired Immunity on Uncomplicated Malaria after Controlled Human Malaria Infection in Adults in Gabon
Bertrand Lell, Benjamin Mordmüller, Jean-Claude Dejon Agobe, et al.
Nature
|
February 16, 2017
Sterile protection against human malaria by chemoattenuated PfSPZ vaccine
Benjamin Mordmüller, Güzin Surat, Heimo Lagler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 30, 2019
Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian Adults
Said A Jongo, L W Preston Church, Ali T Mtoro, et al.
The American Journal of Tropical Medicine and Hygiene
|
November 17, 2017
Advancing Global Health through Development and Clinical Trials Partnerships: A Randomized, Placebo-Controlled, Double-Blind Assessment of Safety, Tolerability, and Immunogenicity of PfSPZ Vaccine for Malaria in Healthy Equatoguinean Men
Ally Olotu, Vicente Urbano, Ali Hamad, et al.
The American Journal of Tropical Medicine and Hygiene
|
June 27, 2018
Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of <i>Plasmodium falciparum</i> Sporozoite Vaccine in Tanzanian Adults
Said A Jongo, Seif A Shekalaghe, L W Preston Church, et al.
The American Journal of Tropical Medicine and Hygiene
|
April 18, 2019
Safety and Differential Antibody and T-Cell Responses to the <i>Plasmodium falciparum</i> Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants
Said A Jongo, L W Preston Church, Ali T Mtoro, et al.
The Lancet. Infectious Diseases
|
February 21, 2017
Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial
Mahamadou S Sissoko, Sara A Healy, Abdoulaye Katile, et al.
Page
of 2